Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Here is What Hedge Funds Think About Celldex Therapeutics, Inc. (CLDX)

Because Celldex Therapeutics, Inc. (NASDAQ:CLDX) has experienced a decline in interest from the aggregate hedge fund industry, we can see that there exists a select few money managers who were dropping their positions entirely in the third quarter. At the top of the heap, Mitchell Blutt’s Consonance Capital Management dropped the largest stake of the 700 funds followed by Insider Monkey, totaling about $19 million in stock, and Behzad Aghazadeh’s venBio Select Advisor was right behind this move, as the fund cut about $8.9 million worth of shares.

Let’s now review hedge fund activity in other stocks – not necessarily in the same industry as Celldex Therapeutics, Inc. (NASDAQ:CLDX) but similarly valued. We will take a look at Diodes Incorporated (NASDAQ:DIOD), TherapeuticsMD Inc (NYSEMKT:TXMD), MBIA Inc. (NYSE:MBI), and Outerwall Inc (NASDAQ:OUTR). This group of stocks’ market caps match CLDX’s market cap.

Ticker No of HFs with positions Total Value of HF Positions (x1000) Change in HF Position
DIOD 13 79294 -4
TXMD 13 47116 0
MBI 30 263054 2
OUTR 28 388498 -2

As you can see these stocks had an average of 21 hedge funds with bullish positions and the average amount invested in these stocks was $194 million. That figure was just $52 million in CLDX’s case. MBIA Inc. (NYSE:MBI) is the most popular stock in this table. On the other hand Diodes Incorporated (NASDAQ:DIOD) and TherapeuticsMD Inc (NYSEMKT:TXMD) are the least popular ones with only 13 bullish hedge fund positions. Celldex Therapeutics, Inc. (NASDAQ:CLDX) is not the least popular stock in this group, but hedge fund interest is still below average. This is a slightly negative signal and we’d rather spend our time researching stocks that hedge funds are piling on. In this regard MBI might be a better candidate to consider a long position.

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.